Apellis Pharmaceuticals, Inc.
APLS
$41.06
$0.040.10%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.17% | -2.59% | 28.14% | 3.44% | -12.93% |
| Total Receivables | 20.57% | 4.10% | 54.71% | -6.20% | -10.06% |
| Inventory | -7.70% | 16.94% | 2.10% | 29.21% | 13.76% |
| Prepaid Expenses | 82.68% | -8.81% | -22.53% | -16.52% | 69.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.89% | 9.44% | 27.77% | 53.02% | 21.30% |
| Total Current Assets | 1.30% | 2.44% | 31.11% | 3.83% | -7.76% |
|
|
|||||
| Total Current Assets | 1.30% | 2.44% | 31.11% | 3.83% | -7.76% |
| Net Property, Plant & Equipment | 2.31% | -8.06% | 29.20% | -5.69% | -6.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -15.71% | -12.69% | -5.36% | -20.67% | -19.80% |
| Total Assets | 0.68% | 1.56% | 28.89% | 1.75% | -8.79% |
|
|
|||||
| Total Accounts Payable | -13.64% | 47.14% | -28.83% | -1.89% | 43.33% |
| Total Accrued Expenses | -19.49% | 18.33% | 0.95% | 19.68% | -17.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.04% | 0.15% | 1,256.02% | 6.84% | 2.83% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -12.41% | 15.77% | 39.30% | 12.49% | -3.84% |
|
|
|||||
| Total Current Liabilities | -12.41% | 15.77% | 39.30% | 12.49% | -3.84% |
| Long-Term Debt | 0.16% | 0.16% | -20.47% | 0.14% | 0.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.20% | -12.67% | 64.56% | -9.50% | -9.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.29% | 142.65% | 56.74% | -0.29% | -73.86% |
| Total Liabilities | -5.32% | 7.23% | -1.13% | 3.42% | -2.05% |
|
|
|||||
| Common Stock & APIC | 0.78% | 0.82% | 0.87% | 1.02% | 0.85% |
| Retained Earnings | 0.62% | -2.00% | 6.81% | -1.35% | -3.04% |
| Treasury Stock & Other | -14.65% | 12.38% | 6.58% | 15.88% | 7.68% |
| Total Common Equity | 12.10% | -7.73% | 156.66% | -4.82% | -28.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.10% | -7.73% | 156.66% | -4.82% | -28.15% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.10% | -7.73% | 156.66% | -4.82% | -28.15% |
|
|
|||||